Bio-Rad Labs Inc. A buy UBS Group AG
Start price
16.02.24
/
50%
€316.20
Target price
16.02.25
€389.51
Performance (%)
-4.68%
Price
09:01
€301.40
Summary
This prediction is currently active. With a performance of -4.68%, the BUY prediction for Bio-Rad Labs Inc. A by UBS_Group_AG is down slightly. This prediction currently runs until 16.02.25. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Bio-Rad Labs Inc. A | 4.587% | 4.587% |
iShares Core DAX® | -3.935% | -3.998% |
iShares Nasdaq 100 | -3.608% | -9.386% |
iShares Nikkei 225® | -4.513% | -8.017% |
iShares S&P 500 | -2.607% | -4.265% |
Comments by UBS_Group_AG for this prediction
In the thread Bio-Rad Labs Inc. A diskutieren
Bio-Rad Laboratories, Inc. (NYSE: BIO) had its price target raised by analysts at UBS Group AG from $395.00 to $420.00. They now have a "buy" rating on the stock.
Ratings data for BIO provided by MarketBeat
Stopped prediction by UBS_Group_AG for Bio-Rad Labs Inc. A
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€248.20
08.05.24
08.05.24
€357.93
08.05.25
08.05.25
21.43%
09:01
09:01
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€285.60
07.12.23
07.12.23
€365.97
07.12.24
07.12.24
5.53%
09:01
09:01